A group of researchers at the Institute for Biomedical Research of Barcelona is working on a pioneering treatment for idiopathic pulmonary fibrosis based on an innovative hypothesis: the transplant of type II pneumocytes, the cells that allow the lung to exchange gases
STAFF | February 11th, 2011